Pediatric anaphylaxis

Pediatric Emergency Care

Volumn 23, Issue 1, 2007, Pages 49-56

  Lane, Roni D ^a   Bolte, Robert G ^a  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

Anaphylaxis; Epinephrine

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; CONTRAST MEDIUM; CORTICOSTEROID; DIPHENHYDRAMINE; DIPHTHERIA VACCINE; GLUCAGON; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; INFLUENZA VACCINE; LATEX; LORATADINE; MEASLES MUMPS RUBELLA VACCINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PENICILLIN G; PERTUSSIS VACCINE; PROPOFOL; RABIES VACCINE; RANITIDINE; TETANUS TOXOID;

ANAPHYLAXIS; CLINICAL FEATURE; CONTINUING EDUCATION; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; EGG ALLERGY; ENVENOMATION; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; INCIDENCE; MILK ALLERGY; MORBIDITY; MORTALITY; MOUSE STRAIN; NONHUMAN; NUT; PATHOPHYSIOLOGY; PEANUT ALLERGY; PEDIATRICS; PULSE OXIMETRY; RABBIT; REPEATED DRUG DOSE; REVIEW; SCIENTIFIC LITERATURE; SHELLFISH POISONING; SOYBEAN; VOMITING;

ALGORITHMS; ANAPHYLAXIS; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; PEDIATRICS;

EID: 33846330574     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e31802d4b87     Document Type: Review

References (55)

1. Ring J, Brockow K, Behrendt H. History and classification of anaphylaxis. Novartis Found Symp. 2004;257:6-16. discussion 16-24, 45-50, 276-285.
2. Cohen SG, Zelaya-Quesada M. Portier, Richet, and the discovery of anaphylaxis: a centennial. J Allergy Clin Immunol. 2002;110(2):331-336.
3. Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60(4):443-451.
4. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second Symposium on the Definition and Management of Anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-397.
5. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115(3 suppl 2):S483-S523.
6. Sampson HA, Munoz-Furlong A, Bock SA, et al. Symposium on the Definition and Management of Anaphylaxis: summary report. J Allergy Clin Immunol. 2005;115(3):584-591.
7. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161(1):15-21.
8. Bohlke K, Davis RL, DeStefano F, et al. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. 2004;113(3):536-542.
9. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol. 1999;104(2 Pt 1):452-456.
10. Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child. 2002;86(4):236-239.
11. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med. 2004;164(3):317-319.
12. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327(6):380-384.
13. Kemp SF, Lockey RF, Wolf BL, et al. Anaphylaxis. A review of 266 cases. Arch Intern Med. 1995;155(16):1749-1754.
14. Cianferoni A, Novembre E, Pucci N, et al. Anaphylaxis: a 7-year follow-up survey of 46 children. Ann Allergy Asthma Immunol. 2004;92(4):464-468.
15. Vander Leek TK, Liu AH, Stefanski K, et al. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr. 2000;137(6):749-755.
16. Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics. 2000;106(4):762-766.
17. Lieberman P. Anaphylaxis. Med Clin North Am. 2006;90(1):77-95. viii.
18. Braganza SC, Acworth JP, McKinnon DR, et al. Paediatric emergency department anaphylaxis: different patterns from adults. Arch Dis Child. 2006;91(2):159-163.
19. Novembre E, Cianferoni A, Bernardini R, et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics. 1998;101(4):E8.
20. Wiener ES, Bajaj L. Diagnosis and emergent management of anaphylaxis in children. Adv Pediatr. 2005;52:195-206.
21. Kagy L, Blaiss MS. Anaphylaxis in children. Pediatr Ann. 1998;27(11):727-734.
22. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003;111(6 Pt 3):1601-1608.
23. Hill DJ, Hosking CS, Heine RG. Clinical spectrum of food allergy in children in Australia and South-East Asia: identification and targets for treatment. Ann Med. 1999;31(4):272-281.
24. Fleisher GR, Ludwig S, Henretig FM, eds. Textbook of Pediatric Emergency Medicine. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:1077-1081.
25. Pediatrics, A.A.o. In: Pickering LK, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases, B.C. Elk Grove Village, IL: American Academy of Pediatrics; 2006:46-47, 405-406.
26. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005;95(3):217-226. quiz 226, 258.
27. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. CMAJ. 2003;169(4):307-311.
28. Brady WJ Jr, Luber S, Carter CT, et al. Multiphasic anaphylaxis: an uncommon event in the emergency department. Acad Emerg Med. 1997;4(3):193-197.
29. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986;78(1 Pt 1):76-83.
30. Dibs SD, Baker MD. Anaphylaxis in children: a 5-year experience. Pediatrics. 1997;99(1):E7.
31. American Heart Association. I., Guidelines 2000 for Cardiopulmonary Resuscitation. Circulation. 2000;102(8 suppl):I229-I252.
32. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care. 1986;14(1):17-21.
33. Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas. 2004;16(2):120-124.
34. Lin RY, Schwartz LB, Curry A, et al. Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol. 2000;106(1 Pt 1):65-71.
35. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000;53(4):273-276.
36. Schwartz LB, Yunginger JW, Miller J, et al. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest. 1989;83(5):1551-1555.
37. Ha TY, Reed ND. Systemic anaphylaxis in mast-cell-deficient mice of W/Wv and Sl/Sld genotypes. Exp Cell Biol. 1987;55(2):63-68.
38. Takeishi T, Martin TR, Katona IM, et al. Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses. J Clin Invest. 1991;88(2):598-608.
39. Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003;112(2):451-452.
40. Simons FE. Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis. Novartis Found Symp. 2004;257:228-243. discussion 243-247, 276-285.
41. Simons FE, Roberts JR, Gu X, et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998;101(1 Pt 1):33-37.
42. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001;108(5):871-873.
43. Simons FE, Gu X, Johnston LM, et al. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? Pediatrics. 2000;106(5):1040-1044.
44. Rawas-Qalaji MM, Simons FE, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol. 2006;117(2):398-403.
45. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol. 2004;134(3):260-261.
46. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5(4):359-364.
47. Winbery SL, Lieberman PL. Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol. 2002;17:287-317.
48. Simons FE. H1-antihistamines in children. Clin Allergy Immunol. 2002;17:437-464.
49. Emergency medical treatment of anaphylactic reactions. Project Team of The Resuscitation Council (UK). Resuscitation. 1999;41(2):93-99.
50. Anaphylaxis in schools and other childcare settings. AAAAI Board of Directors. American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 1998;102(2):173-176.
51. Kelso JM. A second dose of epinephrine for anaphylaxis: how often needed and how to carry. J Allergy Clin Immunol. 2006;117(2):464-465.
52. Simons FE, Gu X, Silver NA, et al. EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis. J Allergy Clin Immunol. 2002;109(1):171-175.
53. Simons FE, Chan ES, Gu X, et al. Epinephrine for the out-ofhospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical? J Allergy Clin Immunol. 2001;108(6):1040-1044.
54. Murphy KR, Hopp RJ, Kittelson EB, et al. Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. Ann Allergy Asthma Immunol. 2006;96(3):398-405.
55. McIntyre CL, Sheetz AH, Carroll CR, et al. Administration of epinephrine for life-threatening allergic reactions in school settings. Pediatrics. 2005;116(5):1134-1140.